Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-Ibuprofen Topical Gel in DOMS
NCT02324985Phase 2Completed
- Sponsor
- Aponia Laboratories
- Start
- Jan 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexibuprofen in delayed onset muscle soreness (DOMS), sponsored by Aponia Laboratories. Started Jan 2015; status: completed.
02
Drugs
dexibuprofen
03
Conditions
delayed onset muscle soreness (DOMS)
Beyond the preview
Go deeper on NCT02324985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02324985.